Time-adjusted direct medical costs of moderate-to-severe chronic graft-versus-host disease: a retrospective two-center cost analysis in Türkiye
Ant Uzay, Yusuf Celik, Mesut Cimen, Muhammed Emre Guvey, Ecenur Aydemir, Ahmet Can Kucukkurt, Salim Yilmaz · 2026
Read Time-adjusted direct medical costs of moderate-to-severe chronic graft-versus-host disease: a retrospective two-center cost analysis in Türkiye by Ant Uzay, Yusuf Celik, Mesut Cimen, Muhammed Emre Guvey, Ecenur Aydemir, Ahmet Can Kucukkurt, Salim Yilmaz (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13645555.txt.
Description
Ant Uzay and six colleagues measure the daily medical cost of chronic graft-versus-host disease, a long-term complication of donor stem cell transplants, at two private centers in Türkiye. Their records cover fifty patients with moderate to severe disease treated from 2018 to 2023. Because care lasted for very different lengths of time, the team modeled cost per day rather than total cost alone.
Average total direct cost came to about fifty-three thousand dollars per patient, and drugs made up roughly three quarters of that sum. Daily cost ran higher for male patients and fell slightly with older age. Disease severity did not raise the daily rate; instead, severe disease raised total cost by stretching treatment out longer. The authors present the work as early evidence for planning transplant care budgets in middle-income settings.
Catalog record
| CREATOR | Ant Uzay, Yusuf Celik, Mesut Cimen, Muhammed Emre Guvey, Ecenur Aydemir, Ahmet Can Kucukkurt, Salim Yilmaz |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |